Login

Scholarship means a door of opportunity|Onsi Sawiris,Co-Founder and Managing Partner,HOF Capital 00:10:00

Share On Facebook Share On Twitter

Focuses on cloud-based technologies, fintech and enterprise SaaS.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Bandito Resources: Advancing High-Value Projects in Mexico
00:10:00
POET Technologies CEO Dr. Suresh Venkatesan is a global technology leader who has introduced the innovative POET Optical Interposer to the marketplace|Dr. Suresh Venkatesan ,CEO,POET Technologies
00:10:00
Clarent Precision: The Key to Success in Quality Machining and Customer Satisfaction
00:10:00
401k Pitfalls: Simplifying Plans for Better Participation
00:10:00
Japan's Semiconductor Sector: A Strategic Analysis and Outlook | Masa Takeda, Portfolio Manager, SPARX Group.
00:10:00
Meteoric Resources: Revitalizing with New Cobalt Projects in Ontario's Rich Cobalt Belt
00:10:00
Helping Financial Advisors Secure Their Future: Brooklyn Brock on Financial Planning and Business Exits | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
The Evolution of the American Welfare State: Intellectual Foundations and Modern Implications|William Voegeli
00:10:00
April 2020 Update from Nathan Mersereau, President of Planning Alternatives | Nathan Mersereau, President, Planning Alternatives Ltd.
00:10:00
G3 Exploration to Spin Out China Gas Assets via Green Dragon Gas in Landmark Move
00:10:00
Presentation on Atac Resources and their Yukon Carlin-Style Mineralization
00:10:00
PH7 Technologies: Transforming E-Waste into Critical Metals for a Sustainable Future

© 2026 Nehu